Alerdez (dezloratadin) syrup 0.5 mg/ml. 100 ml. vial

$5.70

Manufacturer: India

Purpose: Blocks histamine receptors, treats allergies by reducing symptoms like itching and sneezing.

SKU: MED56274 Category:

Description

Alerdez (dezloratadin) syrup 0.5 mg/ml. 100 ml. vial

Ingredients

Active ingredient: Dezloratadin 0.5 mg/ml.

Dosage

Dosage: The recommended dose for adults and children over 12 years old is 5 ml (corresponding to 2.5 mg dezloratadin) once daily.

Indications

Indications: Alerdez syrup is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria.

Contraindications

Contraindications: Alerdez syrup is contraindicated in patients with known hypersensitivity to dezloratadin or any of the ingredients in the formulation.

Directions

Directions: Shake well before use. Use the provided measuring device to ensure the correct dose. Do not exceed the recommended dosage.

Scientific Evidence

Alerdez (dezloratadin) has been extensively studied for its efficacy in managing allergic conditions. Research published in the Journal of Allergy and Clinical Immunology has shown that dezloratadin significantly improves symptoms of allergic rhinitis compared to a placebo, with a rapid onset of action and long-lasting relief.

Additional Information

It is important to note that Alerdez syrup may cause drowsiness in some individuals. It is advisable to avoid driving or operating heavy machinery until the effects of the medication are known. Consult a healthcare professional before using this product if you are pregnant or breastfeeding.

Pharmacological Effects: Dezloratadin, the active ingredient in Alerdez syrup, is a non-sedating antihistamine that works by blocking the action of histamine in the body. This helps to relieve symptoms of allergies such as sneezing, itching, and runny nose.

Clinical Trials: Clinical trials have demonstrated the efficacy of dezloratadin in improving symptoms of allergic rhinitis and chronic idiopathic urticaria. In a randomized controlled trial published in the Annals of Allergy, Asthma & Immunology, dezloratadin was found to be well-tolerated and effective in reducing symptoms of allergic rhinitis.